Drug Delivery

WuXi STA and Regulus Announce microRNA Development and Manufacturing Collaboration

February 22, 2018

Agreement follows the recent opening of WuXi STA’s oligonucleotide R&D labs in China and the USA SHANGHAI, 22 Feb 2018: STA Pharmaceutical Co., Ltd. (STA), a WuXi AppTec group company and the leading open-access capability and technology platform for small molecule pharmaceutical development and manufacturing, and Regulus Therapeutics Inc. (NASDAQ: RGLS), a biopharmaceutical company leading the discovery […]

ADC Bio developing downstream bioconjugation process

February 12, 2018

New manufacturing paradigm will save 25% of total costs and Specialist Process Innovation Group created to validate approach 12 February 2018, Wales:ADC Biotechnology (ADC Bio) announces that it is developing a revolutionary, ‘downstream bioconjugation’ method that will present a new paradigm in Antibody Drug Conjugate (ADC) development and manufacturing. In contrast to the existing approaches – which […]

iX Biopharma Secures China Patent for WaferiX Drug Delivery Technology

February 8, 2018

Singapore, 8 February 2018 – iX Biopharma Ltd. (“iX Biopharma” or, together with its subsidiaries, “the Group”) is pleased to announce that it has been granted a patent for its WaferiX drug delivery technology by the People’s Republic of China (Patent No. ZL 2013800602813). The patent, which expires on 11 October 2033, allows iX Biopharma […]

Elsevier Welcomes Six Biotech and Pharma Start-ups to The Hive, Supporting the Most Cutting-edge Research in Industry

January 31, 2018

Start-ups working on a range of technologies and discoveries – from AI to immunotherapy – receive complimentary access to Elsevier’s information solutions to accelerate innovation Elsevier, the global information analytics business specializing in science and health, today announced that six start-up companies have been selected from more than 150 global applicants for The Hive, Elsevier’s innovation initiative for biotech and pharmaceutical start-ups. Exscientia, LegoChem Biosciences, 4P-Pharma, […]

44% of Life Science Professionals Already Using or Experimenting with AI and Deep Learning, Finds Survey from The Pistoia Alliance

January 9, 2018

94% expect an increase in use of Machine Learning within two years, but access to quality data and technical expertise is a barrier to adoption The Pistoia Alliance, a global, not for profit alliance that works to lower barriers to innovation in life sciences R&D, is calling on the pharmaceutical and technology industries to support […]

INTERPHEX JAPAN 2017/in-PHARMA JAPAN 2017 concluded with a huge success.

December 7, 2017

INTERPHEX JAPAN 2017 and in-PHARMA JAPAN 2017 were held at Tokyo Big Sight, Japan during 28 -30 June, 2017. Japan’s largest* B-to-B trade show specialised in Pharmaceutical R&D and Manufacturing concluded with a huge success (*in reference to the exhibitor number with the same concept.) 30th anniversary year of INTERPHEX JAPAN ended a remarkable success: […]

STA Pharmaceutical Sees Rapid Growth in MAH Programs in China

December 5, 2017

STA Pharmaceutical (STA) – a China-based global API and Drug Product CDMO – reports that it has seen a rapid uptake in companies with intent to market their products in China using it as a development and manufacturing partner following the CFDA’s announcement of the new Market Authorization Holder (MAH) pilot program last year in […]

Peptides 2018

November 30, 2017
FEEDBACK